Dynamic advances in biological and medical research continue and expand the frontiers of healthcare and life sciences, creating a progressive amalgamation of technology, life science, and medicine, pharmaceutical, and biotechnology.
In this new world of convergence across industries and borders, health systems in both established and emerging markets are seeking new ways to meet the demands of diverse information- and technology-enabled consumers in the global economy. The healthcare and life sciences sector faces a landscape of complexity, challenged by an aging population, convoluted regulatory compliance restrictions; growing competition in R&D, pricing pressures; data, analytics and medical technology advancements; growing consolidation among payers and providers; deepening public-private partnerships; and global healthcare reform efforts.
Complexity in innovation driven industry sectors such as Healthcare and Life Sciences create many competitive opportunities for organizations able to embrace change, testing novel business models, and creating innovative value for of health-related benefits to humankind.
Amrop Hofer Tan offers clients the advantages of knowledge of a globally active firm, international access and resources, while providing the expertise, attention and service of a boutique consultancy. Our professional history and roots in Switzerland – a global hub for multi-disciplinary life sciences – combined with our global activities and local knowledge of growth markets in Asia, has enabled us to build strong relationships in the following diverse sectors:
- Medical Devices and Diagnostics
- Pharmaceuticals and Contract Research Organizations (CROs)
- Research and Development
- Healthcare Services
- Managed Care